Javascript must be enabled to continue!
STUDIES ON THE VARIATION OF DEGREES OF RESISTANCE IN ISONIAZID-RESISTANT TUBERCLE BACILLI 1. Variation of INH-resistant Tubercle Bacilli in the Body of Animal. 2. Variation of INH-resistant Tubercle Bacilli by Serial Animal Passage.
View through CrossRef
Isoniazid resistance in the tubercle bacillus remains a matter of moment to the public health, so research in the behavior of the affected organism concern all who deal with the prevention and care of the still most important communicable disease in Korea. Although many a study disclosed the mystery and potential threat of drug resistance of isoniazid, still conflicting evidence has accumulated in the literature concerning the significance of INH-resistant tubercle bacilli. Several reported studies have shown that isoniazid-resistant mutants of tubercle bacilli may be fully pathogenic for guinea pigs, though these retain all or nearly all of their pathogenicity for white mice(Middiebrook, Morse, 1954). Middlebrook also has shown that isoniazid-resistant mutants of tubercle bacilli recovered in vitro are deficient in endogenous catalase activity and that it is possible to isolate isoniazid-resistant mutants which differ in their magnitude of catalase activity. Therefore there is considerable evidence that tubercle bacilli which are highly resistant to isoniazid have diminution or even virtual loss of pathogenicity for guinea pigs, a property hitherto considered virtually synonymous with pathogenicity for humans(Cohn. Peizer, 1953), Were these highly resistant strains to approve of diminished virulence for humans, it would obviously desirable to attempt to achieve in patients a state of high resistance.
The Korean Academy of Tuberculosis and Respiratory Diseases
Title: STUDIES ON THE VARIATION OF DEGREES OF RESISTANCE IN ISONIAZID-RESISTANT TUBERCLE BACILLI
1. Variation of INH-resistant Tubercle Bacilli in the Body of Animal. 2. Variation of INH-resistant Tubercle Bacilli by Serial Animal Passage.
Description:
Isoniazid resistance in the tubercle bacillus remains a matter of moment to the public health, so research in the behavior of the affected organism concern all who deal with the prevention and care of the still most important communicable disease in Korea.
Although many a study disclosed the mystery and potential threat of drug resistance of isoniazid, still conflicting evidence has accumulated in the literature concerning the significance of INH-resistant tubercle bacilli.
Several reported studies have shown that isoniazid-resistant mutants of tubercle bacilli may be fully pathogenic for guinea pigs, though these retain all or nearly all of their pathogenicity for white mice(Middiebrook, Morse, 1954).
Middlebrook also has shown that isoniazid-resistant mutants of tubercle bacilli recovered in vitro are deficient in endogenous catalase activity and that it is possible to isolate isoniazid-resistant mutants which differ in their magnitude of catalase activity.
Therefore there is considerable evidence that tubercle bacilli which are highly resistant to isoniazid have diminution or even virtual loss of pathogenicity for guinea pigs, a property hitherto considered virtually synonymous with pathogenicity for humans(Cohn.
Peizer, 1953), Were these highly resistant strains to approve of diminished virulence for humans, it would obviously desirable to attempt to achieve in patients a state of high resistance.
Related Results
Expression of platelet C1 inhibitor
Expression of platelet C1 inhibitor
Human platelets contain a pool of C1 inhibitor (C1 INH) distinct from that in plasma. Twelve normal platelet samples washed by centrifugation had a mean platelet C1 INH antigen lev...
Tijelo u opusu Janka Polića Kamova
Tijelo u opusu Janka Polića Kamova
The doctoral disertation is dedicated to the concept of the body in the works of Janko Polić Kamov. The body is approached as a signifier system on the basis of which numerous and ...
EXPERIMENTAL RE-EVALUATION STUDIES ON ISONICOTINIC ACID HYDRAZIDE lN VITRO AND IN VIVO
Ⅰ. In vitro Inhibitory Effects of Isonicotinic Acid Hydrazide (INH) Against Tubercle Bacilli
EXPERIMENTAL RE-EVALUATION STUDIES ON ISONICOTINIC ACID HYDRAZIDE lN VITRO AND IN VIVO
Ⅰ. In vitro Inhibitory Effects of Isonicotinic Acid Hydrazide (INH) Against Tubercle Bacilli
Of course, it is importanat to discover new antituberculous drugs, but it is also very important to know how present anti-tuberculous drugs should be used for tuberculosis control....
Differential regulation of monocyte oxidative burst by isoniazid in healthy and latent tuberculosis-infected subjects
Differential regulation of monocyte oxidative burst by isoniazid in healthy and latent tuberculosis-infected subjects
Introduction
Isoniazid (INH), a first-line drug for tuberculosis, exerts bactericidal effects through inhibition of mycolic acid synthesis. However, its potenti...
Isoniazid resistance profile in rifampicin resistant Mycobacterium tuberculosis
Isoniazid resistance profile in rifampicin resistant Mycobacterium tuberculosis
Background: Multidrug-resistant tuberculosis (MDR-TB) is a global public health problem. Rifampicin (RIF) resistance has been used as a surrogate marker for MDR-TB but isoniazid (...
Application of the resazurin microtitre assay for the detection of isoniazid and/or rifampicin resistant Mycobacterium tuberculosis clinical isolates in Central Vietnam
Application of the resazurin microtitre assay for the detection of isoniazid and/or rifampicin resistant Mycobacterium tuberculosis clinical isolates in Central Vietnam
Background: Drug resistant tuberculosis (DR-TB) remains a global health problem. The diagnosis, treatment, and management of DR-TB are the major challenges to Vietnam National Tube...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDR
plus
assay in Ethiopia
Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDR
plus
assay in Ethiopia
ABSTRACT
Resistance-conferring mutations in
Mycobacterium tuberculosis
...

